Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes

Table 1 Baseline characteristics

Characteristic	No. (%) N = 608
Age, mean (SD), years	70.9 (6.7)
CHA₂DS₂-VAS_C score, mean (SD)^a	3.19 (1.43)
Men	414 (68.1)
Atrial fibrillation	19 (3.1)
Atrial fibrillation by claim	14 (2.3)
Wear time per ECG patch, mean (SD), days	11.17 (2.25)
Beta blocker	115 (18.9)
Digoxin	3 (0.5)
Comorbidities
Hypertension	569 (93.6)
Obesity^b	145 (23.8)
Heart failure	35 (5.8)
Chronic obstructive pulmonary disease	40 (6.6)
Stroke	73 (12)
Prior myocardial infarction	36 (5.9)
Sleep apnea	171 (28.1)

Results are expressed as frequencies (percentage) and mean values (standard deviation) as appropriate
CHA₂DS₂-VAS_C, congestive heart failure, hypertension, age ≥ 75 years (doubled), diabetes, stroke/transient ischemic attack/thromboembolism (doubled), vascular disease (prior myocardial infarction, peripheral artery disease, or aortic plaque), age 65–75 years, sex category (female)
^aCHA₂DS₂-VAS_C score is a clinical prediction score for estimating the risk of stroke in individuals with nonrheumatic atrial fibrillation. An individual’s score can range from 0 to 9, with a high score associated with higher risk. Components include congestive heart failure (1 point); hypertension (1 point); age 75 years (2 points); diabetes (1 point); prior stroke or transient ischemic attack (2 points); vascular disease (1 point); age 65–74 years (1 point); and sex category (female;1 point)
^bObesity is defined through the Health Profile Database using a combination of data types including a documented body mass index of 30 or greater and/or an obesity-related diagnosis or procedure (e.g., bariatric surgery)

ISSN: 1475-2840